BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 9220075)

  • 21. The primary vasculitides: a clinicopathologic correlation.
    Narula N; Gupta S; Narula J
    Am J Clin Pathol; 2005 Dec; 124 Suppl():S84-95. PubMed ID: 16468419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uncommon presentations of primary systemic necrotizing vasculitides: the Great Masquerades.
    Sharma A; Gopalakrishan D; Nada R; Kumar S; Dogra S; Aggarwal MM; Gupta R; Minz RW; Kakkar N; Vashishtha RK; Singh S
    Int J Rheum Dis; 2014 Jun; 17(5):562-72. PubMed ID: 24237487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [New pathogenetic aspects in primary systemic vasculitides].
    Lamprecht P
    Internist (Berl); 2009 Mar; 50(3):291-7. PubMed ID: 19212730
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Are the 1990 American College of Rheumatology vasculitis classification criteria still valid?
    Seeliger B; Sznajd J; Robson JC; Judge A; Craven A; Grayson PC; Suppiah RS; Watts RA; Merkel PA; Luqmani RA
    Rheumatology (Oxford); 2017 Jul; 56(7):1154-1161. PubMed ID: 28379475
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment Guidelines in Vasculitis.
    Kermani TA; Warrington KJ; Dua AB
    Rheum Dis Clin North Am; 2022 Aug; 48(3):705-724. PubMed ID: 35953232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The pathology of vasculitis involving the kidney.
    Jennette JC; Falk RJ
    Am J Kidney Dis; 1994 Jul; 24(1):130-41. PubMed ID: 8023818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Geoepidemiology of systemic vasculitis: comparison of the incidence in two regions of Europe.
    Watts RA; Gonzalez-Gay MA; Lane SE; Garcia-Porrua C; Bentham G; Scott DG
    Ann Rheum Dis; 2001 Feb; 60(2):170-2. PubMed ID: 11156552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Vasculitis 2013. What are the changes introduced in the 2012 Chapel Hill Consensus Conference?].
    Zeher M
    Orv Hetil; 2013 Oct; 154(40):1571-8. PubMed ID: 24077160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Classification of vasculitis.
    Michel BA
    Curr Opin Rheumatol; 1992 Feb; 4(1):3-8. PubMed ID: 1347454
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south-eastern New South Wales.
    Ormerod AS; Cook MC
    Intern Med J; 2008 Nov; 38(11):816-23. PubMed ID: 18771432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiology of systemic vasculitis.
    Lane SE; Watts R; Scott DG
    Curr Rheumatol Rep; 2005 Aug; 7(4):270-5. PubMed ID: 16045829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of classification on the incidence of polyarteritis nodosa and microscopic polyangiitis.
    Watts RA; Jolliffe VA; Carruthers DM; Lockwood M; Scott DG
    Arthritis Rheum; 1996 Jul; 39(7):1208-12. PubMed ID: 8670332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients hospitalized because of small vessel vasculitides with renal involvement in the period 1975-95: organ involvement, anti-neutrophil cytoplasmic antibodies patterns, seasonal attack rates and fluctuation of annual frequencies.
    Tidman M; Olander R; Svalander C; Danielsson D
    J Intern Med; 1998 Aug; 244(2):133-41. PubMed ID: 10095799
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions.
    Gonzalez-Gay MA; Garcia-Porrua C; Guerrero J; Rodriguez-Ledo P; Llorca J
    Arthritis Rheum; 2003 Jun; 49(3):388-93. PubMed ID: 12794795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic vasculitis in adults in northwestern Spain, 1988-1997. Clinical and epidemiologic aspects.
    González-Gay MA; García-Porrúa C
    Medicine (Baltimore); 1999 Sep; 78(5):292-308. PubMed ID: 10499071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EULAR/PReS endorsed consensus criteria for the classification of childhood vasculitides.
    Ozen S; Ruperto N; Dillon MJ; Bagga A; Barron K; Davin JC; Kawasaki T; Lindsley C; Petty RE; Prieur AM; Ravelli A; Woo P
    Ann Rheum Dis; 2006 Jul; 65(7):936-41. PubMed ID: 16322081
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cutaneous vasculitis in a defined population--clinical and epidemiological associations.
    Watts RA; Jolliffe VA; Grattan CE; Elliott J; Lockwood M; Scott DG
    J Rheumatol; 1998 May; 25(5):920-4. PubMed ID: 9598892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unraveling the mystery: clues to systemic vasculitic disorders.
    Clark JA
    AACN Clin Issues; 1995 Nov; 6(4):645-56. PubMed ID: 7493266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy insight: The recognition and treatment of retinal manifestations of systemic vasculitis.
    Aristodemou P; Stanford M
    Nat Clin Pract Rheumatol; 2006 Aug; 2(8):443-51. PubMed ID: 16932736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of pathology in the diagnosis of systemic vasculitis.
    Jennette JC; Falk RJ
    Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S52-6. PubMed ID: 17428368
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.